Varenicline Addition to Psychiatric Medications and Stimulants

Safety and Efficacy Considerations

• The National Comprehensive Cancer Network (NCCN) guidelines recommend monitoring for development or worsening of depression and suicidal ideation/behavior when using varenicline, particularly in patients already on psychiatric medications like Abilify and Viibryd 1
• Varenicline carries a seizure risk, particularly during the first month of treatment, which is a concern in patients with certain medical conditions, according to the NCCN guidelines 1, 2
• Common side effects of varenicline include nausea (30-40% of users), insomnia (14-15%), and abnormal/vivid dreams (10-13%), as reported by Praxis Medical Insights 2

Alternative Therapies and Treatment Approaches

• The NCCN guidelines recommend combination nicotine replacement therapy (NRT) as a first-line therapy, which can be used as an alternative to varenicline, especially in patients taking Adderall 1, 3
• If varenicline is preferred, the NCCN guidelines suggest providing intensive behavioral therapy support and monitoring closely for treatment failure within the first 2-3 weeks 1, 3

Dosing and Follow-up

• The standard dosing of varenicline according to the NCCN guidelines is 0.5 mg once daily for days 1-3, 0.5 mg twice daily for days 4-7, and 1 mg twice daily for weeks 2-12, if tolerated 1
• Follow-up within 2 weeks of starting therapy is essential to assess efficacy and side effects, as recommended by the NCCN guidelines 1, 3